Evidence map›Paper›PMID 28207910›Full record

ArticlePLoS pathogens2017

A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.

Leslie Goo, Laura A VanBlargan, Kimberly A Dowd, Michael S Diamond, Theodore C Pierson

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evolution of Zika virus inVirus evolution · 2025
    Article
  8. Article
  9. Article
  10. Envelope domain III EJournal of virology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Leslie GooViral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America.
Laura A VanBlarganDepartments of Medicine, Molecular Microbiology, Pathology & Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, United States of America.
Kimberly A DowdViral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America.
Michael S DiamondDepartments of Medicine, Molecular Microbiology, Pathology & Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, United States of America.
Theodore C PiersonViral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America.ORCID 0000-0002-3795-4348
National Institutes of Health · USWashington University in St. Louis · US

Funding

Antibody-based Protection against FlavivirsesR01AI073755 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FREMONT, DAVED H. · 2007 to 2022
$11.4M
Mechanisms of Antibody-Mediated Neutralization of Flavivirus InfectionZIAAI000957 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PIERSON, THEODORE · 2009 to 2019
$7.1M
ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSESU01AI073755 · NIAID · WASHINGTON UNIVERSITY · PI James E Crowe, Michael S Diamond · 2024 to 2026
$3.3M
NIAID NIH HHS R01 AI073755NIAID NIH HHS U01 AI073755
6 · The paper itself

Abstract

The structural flexibility or 'breathing' of the envelope (E) protein of flaviviruses allows virions to sample an ensemble of conformations at equilibrium. The molecular basis and functional consequences of virus conformational dynamics are poorly understood. Here, we identified a single mutation at residue 198 (T198F) of the West Nile virus (WNV) E protein domain I-II hinge that regulates virus breathing. The T198F mutation resulted in a ~70-fold increase in sensitivity to neutralization by a monoclonal antibody targeting a cryptic epitope in the fusion loop. Increased exposure of this otherwise poorly accessible fusion loop epitope was accompanied by reduced virus stability in solution at physiological temperatures. Introduction of a mutation at the analogous residue of dengue virus (DENV), but not Zika virus (ZIKV), E protein also increased accessibility of the cryptic fusion loop epitope and decreased virus stability in solution, suggesting that this residue modulates the structural ensembles sampled by distinct flaviviruses at equilibrium in a context dependent manner. Although the T198F mutation did not substantially impair WNV growth kinetics in vitro, studies in mice revealed attenuation of WNV T198F infection. Overall, our study provides insight into the molecular basis and the in vitro and in vivo consequences of flavivirus breathing.

Indexed as

MutationAnimalsAntibodies, NeutralizingAntibodies, ViralAntigens, ViralDengueDengue VirusDisease Models, AnimalEnzyme-Linked Immunosorbent AssayEpitopes, B-LymphocyteMiceMice, Inbred C57BLNeutralization TestsProtein StabilityViral Envelope ProteinsVirulenceAntibodies, NeutralizingAntibodies, ViralAntigens, ViralEpitopes, B-Lymphocyteglycoprotein E, FlavivirusViral Envelope Proteins

Identifiers

PMID28207910
PMCPMC5312798
OpenAlexW2588050071

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.